NS Healthcare is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
White Paper
April 25, 2018
New research appears to show that colon cancer-associated microbiota can be manipulated by specific probiotic strains, resulting in improvements from beneficial bacteria. ProBion tablets were used in the study because of their numerous benefits, such as protective tableting matrix and slow-release capabilities.
Download to find out more.